Clinical trials
5 active studies led by Eccogene, of 11 in all
Source: ClinicalTrials.gov, Studies with Eccogene (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Eccogene or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Eccogene
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Eccogene leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Eccogene or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Eccogene: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Eccogene is in.
From our blog
Stories on the topics Eccogene works in.
Weight Management Supplements in the GLP-1 Era
2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack…
Read
Snoring and Sleep Apnoea Devices: Sleeping Better
An estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Read
Diabetes Medicines: How Treatment Choices Are Changing
WHO counts 830 million people with diabetes, and 59% of adults with diabetes took no medicine for it in 2022…
Read